Navigation Links
Ventana and Biocare Medical sign p63 license agreement to aid in the differential diagnosis of benign and malignant prostate lesions
Date:2/26/2013

) mouse monoclonal antibody has been extremely useful in the differentiation of benign and malignant lesions in conjunction with morphological findings. Numerous articles in top clinical journals have cited the accuracy and utility of p63 as an aid in prostate cancer diagnosis, and it has become the gold standard used by leading hospitals, laboratories and experts worldwide.

"Including p63 in our lung, prostate and breast panels really empowers our Multiplex IHC platform to aid pathologists in making critical decisions and solidifies our passion for patient care and the ability to fight cancer one slide at a time," says Roy Paxton Yih , President & CEO, Biocare Medical, LLC.

"Prostate cancer is one of the most difficult cancers to diagnose, and the p63-based test adds a significant advantage to making the correct diagnosis. We are very excited about our agreement with Ventana, and now Biocare, as it will provide a platform to bring the p63 diagnostic tests to patients worldwide," says Peter F. McKeon , President, AsymmetRx Medical, Inc.

About Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. ("VMSI") (SIX: RO, ROG; OTCQX: RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company's intuitive, integrated staining, workflow management platforms, and digital pathology solutions optimize laboratory efficiencies to reduce errors, support di
'/>"/>

SOURCE Ventana Medical Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
2. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
3. Ventana Supports World Patient Safety Day, July 25
4. Ventana Medical Systems, Inc. develops first-ever fully automated dual-stain technique for miRNA and protein detection in cancer
5. MedeAnalytics Receives Leadership Award from Ventana Research
6. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
7. Medical Device Developers - Network at BIOMEDevice Boston Next Week
8. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
9. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
10. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
11. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 30, 2015 DURECT Corporation (Nasdaq: ... a multi-dose Phase 1 clinical trial of an ... DURECT,s Epigenomic Regulator Program.  DUR-928 is an endogenous, ... broad applicability in metabolic diseases such as nonalcoholic ...  It may also play an important role in ...
(Date:3/30/2015)... , March 30, 2015   GlassesUSA , the ... closing of $12.5 million in new financing led by ... The funding will further GlassesUSA,s aggressive business growth and accelerate ... market of online eyewear, both B2C and B2B. ... , COO Eldad Rothman , and CTO Roy ...
(Date:3/30/2015)... 2015  Zimmer Holdings, Inc. (NYSE and SIX: ... ("EC") has conditionally cleared Zimmer,s proposed acquisition of ... upon Zimmer entering into agreements with a suitable ... package previously submitted to the EC.  Zimmer expects ... term.  As previously announced, the proposed transaction also ...
Breaking Medicine Technology:DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 2Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 3Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 4Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 5
(Date:3/30/2015)... New York (PRWEB) March 30, 2015 ... been filed in California Superior Court on behalf of ... heart birth defect after his mother was prescribed the ... to the March 6th filing in Alameda Superior Court, ... nausea and vomiting that she experienced in the early ...
(Date:3/30/2015)... On March 11, 2015, Elle Magazine, in an article ... new treatment options for dealing with stubborn, unwanted fat. Two ... product. The other three technologies use devices to deliver ultrasound ... cold ( CoolSculpting ) to kill fat cells. (see: goo.gl/NmaB4q) ... to permanently remove unwanted fat," says Dr. Simon Ourian, Medical ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 In a ... March 17th, Governor Chris Christie is championing effective drug ... disorders.New Jersey is scrambling to recover funds to stabilize ... best care for victims of drug and alcohol addiction. ... to those plagued by substance use disorders in New ...
(Date:3/30/2015)... 2015 This report studies the ... the forecast period of 2014 to 2019. This ... of 6.5% from 2014 to 2019. , Further ... report, the global pharmacovigilance and drug safety software ... the basis of functionality, namely, adverse event reporting ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Dr. Daniel Shapiro, ... , AZ, was recently featured on Phoenix’s Channel 12 News ... procedure is a minimally invasive alternative to facelifts developed by ... and his team at Shapiro Aesthetic Plastic Surgery and Skin ... produce this exclusive news story on GenXLift. The story detailed ...
Breaking Medicine News(10 mins):Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4Health News:Dr. Daniel Shapiro Unveils New Minimally Invasive Facelift Procedure on Local Newscast 2
... LOS ANGELES, May 22 Generation Rescue, a,non-profit organization ... illness, today announced the expansion of the organization,through three ... Katie Wright have joined the Board,of Directors., Ms. ... recovered her son Evan from autism. Her latest book, ...
... ... difficulties, MINNEAPOLIS, May 22 ... bringing visibility to,dysphagia -- an often undiagnosed, secondary condition resulting from ... makes swallowing extremely difficult and can lead to dangerous,health threats if ...
... Researchers analyze different proteins in progression of risk factors ... -- New insights into lung disease and lung function ... , The researchers analyzed data from the U.S. National ... Development in Young Adults) observational cohort, which recently completed ...
... that in the dog-eat-dog, look-out-for-No. 1, highly competitive business ... to succeed as an entrepreneur. That statement may sound ... A team led by a University of Missouri researcher ... and women decide to pursue entrepreneurship as a viable ...
... International,(Nasdaq: CHDX ) today announced that CEO, ... Ernst & Young Entrepreneur Of The Year(R) 2008 ... & Young LLP, the awards,program recognizes entrepreneurs who ... performance and personal commitment to,their businesses and communities. ...
... JUPITER, Fla., May 22 Atlas Spine, Inc., ... fusion and non-fusion,products, announced today the national launch ... VBR is a radiolucent MIS compatible spacer,system designed ... of,various pathologies of the thoracic and lumbar spine., ...
Cached Medicine News:Health News:Generation Rescue to Target Treatment-Based Research for Autism and ADHD - Jenny McCarthy, Deirdre Imus, and Katie Wright Join Board 2Health News:Generation Rescue to Target Treatment-Based Research for Autism and ADHD - Jenny McCarthy, Deirdre Imus, and Katie Wright Join Board 3Health News:Stroke Victims Often Suffer From Lack of Nutrients With Undiagnosed Disorder 2Health News:Stroke Victims Often Suffer From Lack of Nutrients With Undiagnosed Disorder 3Health News:CARDIA Studies Open Window on Heart, Lung Diseases 2Health News:CARDIA Studies Open Window on Heart, Lung Diseases 3Health News:Taking care of business shouldn't be just for men 2Health News:Chindex International, CEO, Roberta Lipson Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Finalist in Greater Washington 2Health News:Chindex International, CEO, Roberta Lipson Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Finalist in Greater Washington 3Health News:Atlas Spine Launches Stature(TM) Vertebral Body Replacement System 2
Determination of Prothrombin Time (PT)by STA Analyzers (ISI~1.8).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
For the quantitative in vitro determination of Inorganic Phosphorous in serum....
For the quantitative in vitro determination of Magnesium in serum, plasma and urine...
For the quantitative in vitro determination of Lactate Dehydrogenase (LD) in serum and plasma....
Medicine Products: